Akums Share Price Target, Future Prediction, Prognosis, Forecast 2024, 2025, 2026, 2027, 2028, 2029, 2030, 2031, 2035, 2040, 2050
Are you curious about the potential of Akums stock in the future? Then don’t worry In this blog post, we’ll explore future predictions and discuss factors that might influence the Akums share price in the coming years. We’ll provide Akums share price targets for 2024, 2025, 2026, and even far out to 2030, 2035, 2040, and 2050.
We can do the research and take advice from the stock experts to make this blog about the company’s performance and growth but, Keep in mind that these are just predictions, and the actual price could be higher or lower. But they can give you a general idea of what experts think about the stock’s long-term outlook.
So If you want to know how this stock will perform in the upcoming years, read this blog post completely and properly.
What Is Akums Drugs Ltd.?
Akums Drugs and Pharmaceuticals Ltd. is a prominent pharmaceutical contract development and manufacturing organization (CDMO) based in Delhi, India.
Established in 2004, the company offers a wide range of pharmaceutical products and services both domestically and internationally.
Key Points About Akums Drugs:
CDMO Services: The company specializes in contract manufacturing for various pharmaceutical formulations, including tablets, capsules, liquids, injections, and topical preparations.
Manufacturing Facilities: The company operates multiple manufacturing facilities with a combined annual production capacity of billions of units.
Global Presence: The company exports its products to numerous countries worldwide, expanding its reach and market share.
Research and Development: Akums has dedicated research and development units focused on innovation and product development.
Akums Share Price Growth Chart
Akums Share Price Target 2024
| 2024 | Share Price Target |
|---|---|
| January | x |
| February | x |
| March | x |
| April | x |
| May | x |
| June | x |
| July | x |
| August | x |
| September | ₹999.89 |
| October | ₹1,045.09 |
| November | ₹1,087.56 |
| December | ₹1,126.34 |
By the end of 2024, the company’s stock price might reach ₹1,126.34 per share based on performance and current market data.
ALSO READ:- Biocon Share Price Target
Akums Price Target 2025
| 2025 | Share Price Target |
|---|---|
| January | ₹1,087.89 |
| February | ₹1,075.09 |
| March | ₹1,099.89 |
| April | ₹1,156.09 |
| May | ₹1,168.87 |
| June | ₹1,195.45 |
| July | ₹1,214.56 |
| August | ₹1,247.80 |
| september | ₹1,289.09 |
| October | ₹1,312.78 |
| November | ₹1,328.09 |
| December | ₹1,370.35 |
According to current market analysis and performance, the company’s stock price can reach ₹1,370.35 per share by the end of 2025.
Akums Share Price Target 2026
| 2026 | Share Price Target |
|---|---|
| January | ₹1,378.89 |
| February | ₹1,389.09 |
| March | ₹1,411.90 |
| April | ₹1,423.09 |
| May | ₹1,455.90 |
| June | ₹1,444.09 |
| July | ₹1,456.90 |
| August | ₹1,478.09 |
| September | ₹1,489.57 |
| October | ₹1,499.36 |
| November | ₹1,511.99 |
| December | ₹1,524.16 |
By the end of 2026, the company’s stock price might reach ₹1,524.16 per share based on performance and current market data.
ALSO READ:- Monotype Share Price Target
Akums Share Price Target 2027
| 2027 | Share Price Target |
|---|---|
| January | ₹1,523.89 |
| February | ₹1,534.09 |
| March | ₹1,539.90 |
| April | ₹1,545.80 |
| May | ₹1,524.09 |
| June | ₹1,578.90 |
| July | ₹1,589.09 |
| August | ₹1,590.57 |
| September | ₹1,623.76 |
| October | ₹1,655.36 |
| November | ₹1,679.33 |
| December | ₹1,734.16 |
By the end of 2027, the company’s stock price might reach ₹1,734.16 per share based on performance and current market data.
Akums Share Price Target 2028
| 2028 | Share Price Target |
|---|---|
| January | ₹1,730.89 |
| February | ₹1,756.00 |
| March | ₹1,778.90 |
| April | ₹1,790.56 |
| May | ₹1,823.09 |
| June | ₹1,834.09 |
| July | ₹1,888.46 |
| August | ₹1,879.16 |
| September | ₹1,899.09 |
| October | ₹1,923.78 |
| November | ₹1,945.90 |
| December | ₹1,955.78 |
By the end of 2028, the company’s stock price might reach ₹1,955.78 per share based on performance and current market data.
ALSO READ:- Natco Pharma Share Price Target
Akums Share Price Target 2030
| 2030 | Share Price Target |
|---|---|
| January | ₹2,254.89 |
| February | ₹2,267.56 |
| March | ₹2,298.09 |
| April | ₹2,345.80 |
| May | ₹2,367.00 |
| June | ₹2,391.35 |
| July | ₹2,444.19 |
| August | ₹2,467.09 |
| September | ₹2,490.89 |
| October | ₹2,545.67 |
| November | ₹2,589.80 |
| December | ₹2,622.57 |
According to current market analysis and performance, the company’s stock price can reach ₹2,622.57 per share by the end of 2030.
ALSO READ:- Edelweiss Share Price Target
Akums Share Price Target 2031
| 2031 | Share Price Target |
|---|---|
| March | ₹2,689.24 |
| June | ₹2,756.78 |
| September | ₹2,835.56 |
| December | ₹2,985.09 |
By the end of 2031, the company’s stock price might reach ₹2,985.09 per share based on performance and current market data.
Akums Share Price Target 2035
| 2035 | Share Price Target |
|---|---|
| March | ₹3,654.98 |
| June | ₹3,788.09 |
| September | ₹3,921.47 |
| December | ₹3,987.27 |
By the end of 2035, the company’s stock price might reach ₹3,987.27 per share based on performance and current market data.
ALSO READ:- Indegene Share Price Target
Conclusion
I hope this blog post will help you gain some basic knowledge about Akums Price Target, but remember these forecasts are just a roadmap, not a guaranteed destination. The stock market can be unpredictable, so it’s important to research and consider your investment goals before making any decisions.
But with the knowledge you’ve gained about Akum’s share Price potential, you’re well on your way to making informed choices about your investment journey.
I hope this blog post is helpful for you, If there is any doubt regarding this share price Target then please comment below, and I will reply to you.
Disclaimer:- The information provided in this blog post is for informational purposes only and should not be considered as financial advice We are not SEBI registered advisors. Past performance is not a guarantee of future results. Always do your research and consult with a financial professional before making any investment decisions.
Join WhatsApp Channel
Join Telegram Channel